亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Efficacy and Safety of Lenvatinib-Transcatheter Arterial Chemoembolization Sequential Therapy for Patients with Intermediate-Stage Hepatocellular Carcinoma

医学 肝细胞癌 危险系数 伦瓦提尼 内科学 胃肠病学 经导管动脉化疗栓塞 倾向得分匹配 置信区间 索拉非尼 不利影响
作者
Yuwa Ando,Tomokazu Kawaoka,Kei Amioka,Kensuke Naruto,Yutaro Ogawa,Yuki Yoshikawa,Chihiro Kikukawa,Yumi Kosaka,Shinsuke Uchikawa,Kei Morio,Hatsue Fujino,Takashi Nakahara,Eisuke Murakami,Masami Yamauchi,Masataka Tsuge,Akira Hiramatsu,Takayuki Fukuhara,Nami Mori,Shintaro Takaki,Keiji Tsuji
出处
期刊:Oncology [Karger Publishers]
卷期号:99 (8): 507-517 被引量:55
标识
DOI:10.1159/000515865
摘要

INTRODUCTION: We evaluated the efficacy and safety of lenvatinib-transcatheter arterial chemoembolization (LEN-TACE) sequential therapy for patients (n = 88) with intermediate-stage hepatocellular carcinoma (HCC). METHODS: Eighty-eight patients who obtained tumor control by LEN treatment were analyzed; 30 received LEN followed by TACE (LEN-TACE sequential therapy), and 58 received LEN monotherapy. Propensity score matching was performed, and the outcomes of 19 patients in the LEN-TACE group and 19 patients in the LEN-alone group were compared. Objective response rate (ORR), progression-free survival (PFS), overall survival (OS), incidence of adverse events (AEs), and change in albumin-bilirubin (ALBI) score were evaluated. RESULTS: After matching, baseline characteristics were similar between the groups. The ORR was 63.2% with LEN-TACE group and 63.2% with the LEN-alone group. Multivariate analysis showed that addition of TACE during LEN treatment (hazard ratio [HR] 0.264, 95% confidence interval [CI] 0.087-0.802, p = 0.019) and Child-Pugh score 5 (HR 0.223, 95% CI 0.070-0.704, p = 0.011) were the significant factors for PFS. Median PFS was 11.6 months with LEN-TACE and 10.1 months with LEN-alone. The survival rate of the LEN-TACE group was significantly higher than that of the LEN-alone group (median survival time; not reached vs. 16.9 months, p = 0.007). The incidence of common LEN-associated AEs was similar between groups. Although elevated aspartate aminotransferase/alanine aminotransferase and fever were more frequent with LEN-TACE group, these events were manageable. CONCLUSION: For patients with intermediate-stage HCC, LEN-TACE sequential therapy may provide a deep response and favorable prognosis.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
3秒前
朱志伟发布了新的文献求助10
4秒前
等待的弘文完成签到 ,获得积分10
5秒前
cheers发布了新的文献求助10
6秒前
朱志伟完成签到,获得积分10
13秒前
14秒前
高兴夏之完成签到,获得积分10
16秒前
CMJ发布了新的文献求助10
19秒前
pengua发布了新的文献求助10
20秒前
cheers完成签到,获得积分10
21秒前
Ava的应助被风趣含双采纳,获得10
21秒前
Jayzie完成签到 ,获得积分0
21秒前
24秒前
26秒前
田様的应助被soilman采纳,获得10
27秒前
29秒前
Yh发布了新的文献求助30
30秒前
30秒前
CMJ完成签到,获得积分10
30秒前
大个的应助被儒雅傲人采纳,获得10
31秒前
小马甲的应助被儒雅傲人采纳,获得10
31秒前
33秒前
Xenomorph发布了新的文献求助50
33秒前
小棉发布了新的文献求助10
34秒前
辛勤的涵菡完成签到,获得积分10
34秒前
Hello的应助被Brightfuture采纳,获得10
35秒前
风趣含双发布了新的文献求助10
36秒前
40秒前
43秒前
所所的应助被可乐采纳,获得10
45秒前
pengua发布了新的文献求助10
47秒前
yizimm完成签到 ,获得积分10
47秒前
50秒前
Lusteri完成签到 ,获得积分10
51秒前
板栗炒鸡完成签到,获得积分10
54秒前
55秒前
55秒前
畅快怜容完成签到,获得积分20
56秒前
敏感一一完成签到,获得积分10
57秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8172954
求助须知:如何正确求助?哪些是违规求助? 9565479
关于积分的说明 21780097
捐赠科研通 7764853
什么是DOI,文献DOI怎么找? 3431513
关于科研通互助平台的介绍 2555530
邀请新用户注册赠送积分活动 2476595